Voltage-gated Ca2+ channels as key mediators of iron-transport and iron-overload cardiomyopathy: L-type vs. T-type Ca+ channels

被引：10
作者：
Das, Subhash K. [1 ]
Oudit, Gavin Y. [1 ]
机构：
[1] Univ Alberta, Dept Med, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2S2, Canada
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2012年 / 88卷 / 06期
关键词：
D O I：
10.1111/j.1600-0609.2012.01782.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：476 / 477
页数：2
相关论文
共 8 条
[1]   Iron Overload in Human Disease [J].
Fleming, Robert E. ;
Ponka, Prem .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) :348-359
[2]   Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle [J].
Huang, BY ;
Qin, DY ;
Deng, LL ;
Boutjdir, M ;
El-Sherif, N .
CARDIOVASCULAR RESEARCH, 2000, 46 (03) :442-449
[3]   T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice [J].
Kumfu, Sirinart ;
Chattipakorn, Siriporn ;
Chinda, Kroekkiat ;
Fucharoen, Suthat ;
Chattipakorn, Nipon .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (06) :535-548
[4]   Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment [J].
Murphy, Colm J. ;
Oudit, Gavin Y. .
JOURNAL OF CARDIAC FAILURE, 2010, 16 (11) :888-900
[5]   Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy [J].
Oudit, Gavin Y. ;
Trivieri, Maria G. ;
Khaper, Neelam ;
Liu, Peter P. ;
Backx, Peter H. .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2006, 84 (05) :349-364
[6]   Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model [J].
Oudit, GY ;
Trivieri, MG ;
Khaper, N ;
Husain, T ;
Wilson, GJ ;
Liu, P ;
Sole, MJ ;
Backx, PH .
CIRCULATION, 2004, 109 (15) :1877-1885
[7]   L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy [J].
Oudit, GY ;
Sun, H ;
Trivieri, MG ;
Koch, SE ;
Dawood, F ;
Ackerley, C ;
Yazdanpanah, M ;
Wilson, GJ ;
Schwartz, A ;
Liu, PP ;
Backx, PH .
NATURE MEDICINE, 2003, 9 (09) :1187-1194
[8]  
Tanaka H, 2002, CARDIOVASC DRUG REV, V20, P81
1